🟢 Rocket Pharmaceuticals is trading 6.05% up today; no company-specific catalyst identified

Rocket Pharmaceuticals is trading at $3.84, up +6.05%, with no new company-specific announcement identified for August 28, 2026.

• Latest releases covered second-quarter results and August 3 clinical safety progress, not a new August 28 catalyst.
• Broader markets are modestly higher, while biotech is declining, leaving the specific driver unclear.
• A catalyst may emerge later.